The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study

BACKGROUND: Disease modifying anti-rheumatic drugs (DMARDs) may interfere with bone healing. Previous studies give conflicting advice regarding discontinuation of these drugs in the peri-operative setting. No consensus exists in current practice especially with the newer DMARDs such as Leflunomide,...

Descripción completa

Detalles Bibliográficos
Autores principales: Malviya, Ajay, Kuiper, Jan Herman, Makwana, Nilesh, Laing, Patrick, Ashton, Brian
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694161/
https://www.ncbi.nlm.nih.gov/pubmed/19470170
http://dx.doi.org/10.1186/1749-799X-4-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694161/
https://www.ncbi.nlm.nih.gov/pubmed/19470170
http://dx.doi.org/10.1186/1749-799X-4-17

Ejemplares similares